台股 » 個股 » 群創 » 個股(權證)/期貨 » 個股權證

群創

(3481)
可現股當沖
  • 股價
    15.50
  • 漲跌
    ▲0.25
  • 漲幅
    +1.64%
  • 成交量
    42,579
  • 產業
    上市 光電類股
  • 3413人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     

群創 (3481) 個股權證

群創 (3481) 個股權證-認購
權證代號價格漲跌漲跌幅買價賣價成交量成交
波動
買價
波動
賣價
波動
買賣
價差
履約價行使
比例
價內外程度實質
槓桿
剩餘
天數
群創國票41購01 039427 0.77 ▲0.12 +18.46% 0.740.7500.00%0.00%0.00%0.01%15.120.528 價平 -2.513% 0 59
群創元大3C購04 039693 0.09 -- -- 0.10.1100.00%52.69%53.99%0.10%19.130.959 價外 18.975% 0 31
群創凱基43購01 039731 0.56 -- -- 0.640.6500.00%0.00%0.00%0.02%19.290.959 價平 19.647% 0 122
群創群益3C購06 039907 0.34 -- -- 0.290.3900.00%0.00%0.00%0.34%17.720.959 價平 12.528% 0 32
群創中信3C購03 039974 0.03 -- -- 0.020.0300.00%0.00%0.00%0.50%24.40.959 價平 36.475% 0 33
群創中信3C購04 039975 0.01 -- -- 00.0200.00%0.00%0.00%0.00%22.940.959 價平 32.432% 0 33
群創永豐42購01 040002 0.34 ▲0.04 +13.33% 0.340.3500.00%0.00%0.00%0.03%17.720.345 價平 12.528% 0 73
群創永豐42購02 040003 0.64 ▲0.07 +12.28% 0.610.6200.00%0.00%0.00%0.02%20.850.959 價平 25.659% 0 95
群創國票42購01 040029 0.28 -- -- 0.30.3100.00%0.00%0.00%0.03%17.720.575 價平 12.528% 0 73
群創國票42購02 040030 0.22 -- -- 0.240.2500.00%0.00%0.00%0.04%20.850.767 價平 25.659% 0 95
群創群益42購01 040062 0.12 -- -- 0.120.1300.00%0.00%0.00%0.08%23.170.959 價平 33.103% 0 95
群創群益42購02 040063 0.19 -- -- 0.20.2100.00%0.00%0.00%0.05%24.320.959 價平 36.266% 0 95
群創凱基3C購05 040101 0.05 -- -- 0.010.1100.00%0.00%0.00%10.00%22.940.959 價平 32.432% 0 33
群創中信42購01 040200 0.4 -- -- 0.430.4400.00%0.00%0.00%0.02%19.810.48 價平 21.757% 0 96
群創國票3C購03 040208 0.03 -- -- 0.020.0300.00%0.00%0.00%0.50%22.940.959 價平 32.432% 0 34
群創國票42購03 040209 0.57 -- -- 0.60.6100.00%0.00%0.00%0.02%16.680.499 價平 7.074% 0 96
群創國票42購04 040210 0.16 -- -- 0.170.1800.00%0.00%0.00%0.06%19.810.719 價平 21.757% 0 73
群創永豐42購03 040232 0.3 ▲0.04 +15.38% 0.280.2900.00%0.00%0.00%0.04%16.680.269 價平 7.074% 0 73
群創永豐43購01 040233 0.58 ▲0.05 +9.43% 0.540.5600.00%0.00%0.00%0.04%18.770.556 價平 17.421% 0 124
群創凱基46購01 040257 0.29 -- -- 0.310.3200.00%0.00%0.00%0.03%23.980.48 價平 35.363% 0 216
面板雙虎10月營收雙降 友達月減近2成、群創衰退11%Anue鉅亨-15天前
群創 相關文章